AKT1 and hepatocellular carcinoma: In addition to this, another lncRNA NEAT1v1 (nuclear paraspeckle assembly transcript 1 variant 1) activates the AKT pathway via SOD2 leading to sorafenib and lenvatinib resistance with an increase in the sensitivity of HCC cell lines to capivasertib.